{"id":"low-intensity-chemotherapy-regimen","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (anemia, thrombocytopenia, neutropenia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Low-intensity chemotherapy (also called reduced-intensity or metronomic chemotherapy) delivers chemotherapeutic drugs at lower doses, either continuously or at frequent intervals, rather than in high-dose pulses. This approach aims to maintain anti-tumor efficacy while reducing severe adverse effects, making it suitable for elderly patients, those with comorbidities, or those unable to tolerate standard-dose regimens. The mechanism relies on direct cytotoxicity against cancer cells and may also involve anti-angiogenic effects through continuous low-dose exposure.","oneSentence":"Low-intensity chemotherapy regimens use reduced doses of cytotoxic agents to kill rapidly dividing cancer cells while minimizing toxicity in vulnerable patient populations.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:19:38.165Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hematologic malignancies in elderly or frail patients"},{"name":"Acute myeloid leukemia (AML) in patients ineligible for intensive chemotherapy"}]},"trialDetails":[{"nctId":"NCT02905591","phase":"PHASE2","title":"A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Joseph J. Cullen, MD, FACS","startDate":"2018-11-16","conditions":"Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer","enrollment":43},{"nctId":"NCT07493161","phase":"NA","title":"Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-04-01","conditions":"Ph+ ALL","enrollment":100},{"nctId":"NCT06985485","phase":"PHASE2","title":"Full-Course Immunotherapy Consolidation for Unfit or Fit B-ALL Who Decline Chemotherapy","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-05-17","conditions":"Acute Lymphoblastic Leukemia, Immunotherapy, Blinatumomab","enrollment":26},{"nctId":"NCT07484932","phase":"NA","title":"TRTRM (ACTTOP) -Guided Dosing Strategy in Older Patients With Cancer","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2026-05-01","conditions":"Cancer (Solid Tumors), Geriatric Oncology","enrollment":400},{"nctId":"NCT05941741","phase":"PHASE3","title":"IC Plus Low-dose Radiation Plus Cadonilimab in LANPC","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-01-10","conditions":"Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy","enrollment":380},{"nctId":"NCT06412510","phase":"PHASE1, PHASE2","title":"Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","startDate":"2025-09-05","conditions":"Ovarian Cancer, Epithelial Ovarian Cancer, Pancreatic Adenocarcinoma","enrollment":22},{"nctId":"NCT06713837","phase":"PHASE3","title":"IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.","status":"RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2025-02-27","conditions":"Acute Myeloid Leukemia, Relapse/Recurrence","enrollment":339},{"nctId":"NCT03070327","phase":"PHASE1","title":"BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2017-02-27","conditions":"Multiple Myeloma","enrollment":20},{"nctId":"NCT07294677","phase":"PHASE1, PHASE2","title":"CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2026-03-17","conditions":"Leukemia, Lymphoma","enrollment":104},{"nctId":"NCT06446661","phase":"NA","title":"Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia","status":"NOT_YET_RECRUITING","sponsor":"University of Chicago","startDate":"2026-12-15","conditions":"Acute Lymphoblastic Leukemia","enrollment":38},{"nctId":"NCT06483906","phase":"PHASE2","title":"Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.","status":"RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2024-07-02","conditions":"Acute Myeloid Leukemia","enrollment":56},{"nctId":"NCT02031250","phase":"PHASE2","title":"Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2014-02","conditions":"Squamous Cell Carcinoma of the Head and Neck","enrollment":106},{"nctId":"NCT07153796","phase":"PHASE2","title":"A Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-cell Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2026-01-30","conditions":"B-cell Acute Lymphoblastic Leukemia","enrollment":60},{"nctId":"NCT03174275","phase":"PHASE2","title":"Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2017-12-19","conditions":"Carcinoma, Squamous Cell, Oral Cancer, Oropharynx Cancer","enrollment":39},{"nctId":"NCT03729518","phase":"NA","title":"TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck","status":"ACTIVE_NOT_RECRUITING","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2018-10-11","conditions":"Oropharyngeal Cancer, Squamous Cell Carcinoma, Human Papilloma Virus","enrollment":150},{"nctId":"NCT03147612","phase":"PHASE2","title":"Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-02-08","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With BCR-ABL1","enrollment":22},{"nctId":"NCT04994717","phase":"PHASE3","title":"Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"Amgen","startDate":"2021-11-02","conditions":"Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)","enrollment":304},{"nctId":"NCT05062317","phase":"PHASE2","title":"ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-04-26","conditions":"Liver Metastases","enrollment":120},{"nctId":"NCT07386444","phase":"NA","title":"Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy","status":"RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2026-02-19","conditions":"Early Stage Breast Carcinoma, Dyspnea","enrollment":58},{"nctId":"NCT05691010","phase":"EARLY_PHASE1","title":"A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-01-10","conditions":"Endometrial Cancer, Stage III Endometrial Cancer, Stage III Endometrial Carcinoma","enrollment":28},{"nctId":"NCT07330141","phase":"NA","title":"Optimizing Recovery in Pediatric ALL Survivors: A Training Comparison","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-12-03","conditions":"Acute Lymphobkastic Leukemia","enrollment":72},{"nctId":"NCT03808610","phase":"PHASE1, PHASE2","title":"Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2019-04-03","conditions":"Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia","enrollment":50},{"nctId":"NCT07327138","phase":"NA","title":"Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.","status":"RECRUITING","sponsor":"Bahaa Bou Dargham","startDate":"2025-10-15","conditions":"Acute Lymphoblastic Leukemia ALL","enrollment":60},{"nctId":"NCT05803889","phase":"","title":"Characterization and Kinetic of Chemotherapy-induced Cardiovascular Toxicity in Breast Cancer","status":"TERMINATED","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2023-09-21","conditions":"Breast Cancer","enrollment":2},{"nctId":"NCT00980954","phase":"PHASE3","title":"Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy","status":"COMPLETED","sponsor":"Radiation Therapy Oncology Group","startDate":"2009-09","conditions":"Cervical Cancer","enrollment":236},{"nctId":"NCT01371630","phase":"PHASE1, PHASE2","title":"Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-08-26","conditions":"B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt-Like Lymphoma With 11q Aberration","enrollment":276},{"nctId":"NCT01871766","phase":"PHASE2","title":"Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-12-04","conditions":"Rhabdomyosarcoma","enrollment":115},{"nctId":"NCT05672173","phase":"PHASE2","title":"Lisocabtagene Maraleucel, Nivolumab and Ibrutinib for the Treatment of Richter's Transformation","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2023-06-02","conditions":"Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic Leukemia, Richter Syndrome","enrollment":20},{"nctId":"NCT02066220","phase":"PHASE2, PHASE3","title":"International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitätsklinikum Hamburg-Eppendorf","startDate":"2014-06","conditions":"Brain Tumors","enrollment":360},{"nctId":"NCT06846450","phase":"PHASE3","title":"Phase 3 Trial Comparing IMRT or IMPT Plus CIRT for Patients With NPC","status":"RECRUITING","sponsor":"Lin Kong, MD","startDate":"2025-04-01","conditions":"Nasopharyngeal Cancinoma (NPC)","enrollment":470},{"nctId":"NCT06630780","phase":"NA","title":"Reduction of Postoperative Radiotherapy in Head and Neck Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-01-26","conditions":"Head and Neck Squamous Cell Carcinoma (HNSCC)","enrollment":50},{"nctId":"NCT05293197","phase":"PHASE1","title":"Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-02-06","conditions":"Malignant Brain Tumor, Malignant Glioma, Embryonal Tumor","enrollment":24},{"nctId":"NCT01878617","phase":"PHASE2","title":"A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2013-06-23","conditions":"Medulloblastoma","enrollment":660},{"nctId":"NCT05902169","phase":"PHASE3","title":"Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM","status":"ACTIVE_NOT_RECRUITING","sponsor":"CarThera","startDate":"2024-01-29","conditions":"Glioblastoma, Recurrent Glioblastoma, GBM","enrollment":560},{"nctId":"NCT07014462","phase":"PHASE1","title":"A Phase 1B Investigator Initiated Study of Safety and Tolerability of Dexamethasone (D) in Combination With Venetoclax-based Low-Intensity Therapy (LIT) in Treatment-Naïve Acute Myeloid Leukemia (AML): DLIT-AML","status":"ENROLLING_BY_INVITATION","sponsor":"University of Vermont","startDate":"2025-09-01","conditions":"AML - Acute Myeloid Leukemia","enrollment":20},{"nctId":"NCT07177443","phase":"PHASE3","title":"Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-09-25","conditions":"Locally Advanced Nasopharyngeal Carcinoma","enrollment":456},{"nctId":"NCT05570422","phase":"PHASE1","title":"A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01","status":"NOT_YET_RECRUITING","sponsor":"Kortuc, Inc.","startDate":"2025-12-01","conditions":"Cervical Cancer","enrollment":70},{"nctId":"NCT06522971","phase":"NA","title":"Effects of Physical Exercise on Response to Treatement in Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Latvian Biomedical Research and Study Centre","startDate":"2022-08-16","conditions":"Breast Cancer","enrollment":55},{"nctId":"NCT07162714","phase":"PHASE2","title":"SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2025-09-01","conditions":"Rectal Cancer, Radiation, AK112","enrollment":30},{"nctId":"NCT06947577","phase":"PHASE4","title":"Pulsed Electromagnetic Field Therapy to a Tailored Exercise Program for Patients Suffering From Chemotherapy-induced Neuropathy Related to Breast Cancer","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-05-01","conditions":"Neuropathic","enrollment":80},{"nctId":"NCT06950190","phase":"PHASE3","title":"Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)","status":"ENROLLING_BY_INVITATION","sponsor":"Ellis Medicine","startDate":"2025-06-09","conditions":"Chemotherapy-related Cognitive Impairment","enrollment":100},{"nctId":"NCT07112482","phase":"NA","title":"Effect of Dietary Counseling and Nutritional Monitoring in Reducing Cancer-related Cachexia Among Female Oncology Patients","status":"COMPLETED","sponsor":"Pakistan Society of Pediatric Oncology","startDate":"2024-08-15","conditions":"Breast Cancer, Cachexia","enrollment":140},{"nctId":"NCT05032183","phase":"PHASE1, PHASE2","title":"Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-02-17","conditions":"Recurrent Adult Lymphoblastic Lymphoma, Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia","enrollment":4},{"nctId":"NCT06930105","phase":"PHASE2","title":"Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALL","status":"NOT_YET_RECRUITING","sponsor":"Xianmin Song, MD","startDate":"2025-09-01","conditions":"Acute Lymphoid Leukemia (ALL)","enrollment":45},{"nctId":"NCT03793478","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2018-08-15","conditions":"Acute Myeloid Leukemia","enrollment":65},{"nctId":"NCT07093827","phase":"","title":"A Prospective Cohort Study on the Effect of Spinal Spinal Cord Injury on Sexual Function in Male Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2020-01-01","conditions":"Sexual Function Abnormal, Spinal Cord Injuries (SCI)","enrollment":1600},{"nctId":"NCT04900623","phase":"PHASE2","title":"Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study","status":"RECRUITING","sponsor":"Jonathan Schoenfeld, MD, MPH","startDate":"2021-07-02","conditions":"HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage","enrollment":145},{"nctId":"NCT07088484","phase":"","title":"Watch-and-Wait After Immunochemotherapy in Locally Recurrent Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Fujian Cancer Hospital","startDate":"2025-08-01","conditions":"Recurrent Nasopharyngeal Carcinoma","enrollment":50},{"nctId":"NCT07070622","phase":"PHASE3","title":"Planed Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR)","status":"RECRUITING","sponsor":"West China Hospital","startDate":"2024-11-01","conditions":"Rectal Cancer","enrollment":186},{"nctId":"NCT07061769","phase":"NA","title":"Helping Cancer Patients Manage Neuropathy Symptoms From Chemotherapy With a Low-Intensity, Low-Risk Cranial PEMF Device","status":"ENROLLING_BY_INVITATION","sponsor":"FluxWear, INC","startDate":"2025-06-23","conditions":"Chemotherapy Induced Peripheral Neuropathy, Chemotherapy Induced Peripheral Neuropathy (CIPN), Chemotherapy Induced Pain Neuropathy","enrollment":50},{"nctId":"NCT07059741","phase":"NA","title":"Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2024-12-10","conditions":"Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)","enrollment":20},{"nctId":"NCT05388773","phase":"PHASE2","title":"Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer","status":"RECRUITING","sponsor":"Heath Skinner","startDate":"2022-07-20","conditions":"Oropharynx Cancer","enrollment":150},{"nctId":"NCT01350232","phase":"NA","title":"Treatment of Sickle Cell Anemia With Stem Cell Transplant","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2009-09","conditions":"Sickle Cell Anemia, Sickle Cell-hemoglobin C Disease, Sickle Cell-β0-thalassemia","enrollment":2},{"nctId":"NCT04456322","phase":"PHASE3","title":"Radiotherapy Plus Nimotuzumab or Cisplatin in Nasopharyngeal Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2020-08-17","conditions":"Nasopharyngeal Carcinoma","enrollment":381},{"nctId":"NCT06061094","phase":"PHASE2","title":"Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT","status":"RECRUITING","sponsor":"Goethe University","startDate":"2023-07-14","conditions":"Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia","enrollment":220},{"nctId":"NCT05304468","phase":"PHASE3","title":"Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2022-05-11","conditions":"Nasopharyngeal Carcinoma","enrollment":452},{"nctId":"NCT06561152","phase":"PHASE1, PHASE2","title":"Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML","status":"RECRUITING","sponsor":"Stanford University","startDate":"2025-02-10","conditions":"Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia","enrollment":20},{"nctId":"NCT06876701","phase":"EARLY_PHASE1","title":"The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults","status":"NOT_YET_RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-04-01","conditions":"Acute Leukemia","enrollment":10},{"nctId":"NCT06873672","phase":"","title":"Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-04-01","conditions":"Quality of Life (QOL), Patient-Reported Outcome Measures (PROMs), Pneumonia Childhood","enrollment":360},{"nctId":"NCT05216653","phase":"PHASE2","title":"Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM)","status":"COMPLETED","sponsor":"Sir Run Run Shaw Hospital","startDate":"2022-04-07","conditions":"MSS Locally Advanced Rectal Adenocarcinoma","enrollment":32},{"nctId":"NCT01898494","phase":"PHASE2","title":"Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ECOG-ACRIN Cancer Research Group","startDate":"2014-01-22","conditions":"Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx","enrollment":519},{"nctId":"NCT06779435","phase":"","title":"A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2025-01-01","conditions":"DLBCL","enrollment":400},{"nctId":"NCT03763253","phase":"PHASE2","title":"Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms","status":"ACTIVE_NOT_RECRUITING","sponsor":"Imperial College London","startDate":"2019-04-10","conditions":"Prostate Cancer, Metastatic Prostate Cancer","enrollment":433},{"nctId":"NCT06280885","phase":"NA","title":"A Flexible Individualized ExeRcise Programme for Cancer Patients During ChEmotherapy","status":"RECRUITING","sponsor":"University of Dublin, Trinity College","startDate":"2025-01-01","conditions":"Cancer","enrollment":50},{"nctId":"NCT06197776","phase":"","title":"Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-07-15","conditions":"Multi-omics Technique, Nasopharyngeal Carcinoma, Recurrent and Metastatic Nasopharyngeal Carcinoma","enrollment":50},{"nctId":"NCT05780372","phase":"PHASE3","title":"Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-08-08","conditions":"Nasopharyngeal Carcinoma, Radiotherapy; Complications","enrollment":474},{"nctId":"NCT06766903","phase":"NA","title":"Onco-Vascular Exer-Study","status":"COMPLETED","sponsor":"Cristian Alvarez","startDate":"2024-04-01","conditions":"Breast Cancer, Vascular Disease，Peripheral, Arterial Hypertension","enrollment":30},{"nctId":"NCT02281955","phase":"PHASE2","title":"De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2014-08","conditions":"Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms","enrollment":115},{"nctId":"NCT04476576","phase":"NA","title":"Aerobic Exercise is Cardio-protective in Hemato-oncological Disease and New-onset Chemotherapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lucía Florio","startDate":"2021-03-02","conditions":"Cardiotoxicity, Systolic Dysfunction, Exercise, Aerobic","enrollment":38},{"nctId":"NCT05453682","phase":"NA","title":"Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2021-05-14","conditions":"Bladder Cancer","enrollment":53},{"nctId":"NCT06444009","phase":"PHASE2","title":"A Phase II Study of Neoadjuvant Immunotherapy in Combination With Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Lei Liu","startDate":"2024-07-01","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":90},{"nctId":"NCT05919030","phase":"PHASE3","title":"A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Renmin Hospital of Wuhan University","startDate":"2023-07-01","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":155},{"nctId":"NCT01530997","phase":"PHASE2","title":"De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2012-02-07","conditions":"Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms","enrollment":45},{"nctId":"NCT05904340","phase":"NA","title":"Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy","status":"RECRUITING","sponsor":"National Taipei University of Nursing and Health Sciences","startDate":"2023-07-01","conditions":"Breast Neoplasms, Chemotherapy-induced Peripheral Neuropathy","enrollment":86},{"nctId":"NCT06647563","phase":"PHASE3","title":"Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","startDate":"2024-11-01","conditions":"Squamous Cell Carcinoma of Head and Neck","enrollment":355},{"nctId":"NCT04258969","phase":"NA","title":"Pedaling at a Low-Moderate Intensity During Chemotherapy Administration","status":"WITHDRAWN","sponsor":"Rush University Medical Center","startDate":"2020-01-11","conditions":"Colorectal Cancer, Exercise, Aerobic, Chemotherapy","enrollment":""},{"nctId":"NCT02582775","phase":"PHASE2","title":"MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2016-03","conditions":"Epidermolysis Bullosa","enrollment":17},{"nctId":"NCT05979961","phase":"PHASE3","title":"Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-09-07","conditions":"Nasopharyngeal Carcinoma","enrollment":454},{"nctId":"NCT04072393","phase":"NA","title":"Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2021-01-15","conditions":"Lung Cancer, Esophageal Cancer, Thoracic Cancer","enrollment":24},{"nctId":"NCT05011149","phase":"PHASE3","title":"Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilot RCT","status":"RECRUITING","sponsor":"IWK Health Centre","startDate":"2022-01-10","conditions":"Patent Ductus Arteriosus After Premature Birth","enrollment":100},{"nctId":"NCT06451302","phase":"NA","title":"Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yizhuo Zhang","startDate":"2024-04-17","conditions":"Ewing Sarcoma, Risk Stratification","enrollment":100},{"nctId":"NCT06418776","phase":"PHASE3","title":"IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML","status":"RECRUITING","sponsor":"National Research Center for Hematology, Russia","startDate":"2024-04-01","conditions":"Refractory Acute Myeloid Leukemia, Early Relapses of Acute Myeloid Leukemia","enrollment":198},{"nctId":"NCT05441722","phase":"NA","title":"CIPN in Early Stage Breast Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northumbria University","startDate":"2022-05-26","conditions":"Breast Cancer, Chemotherapy-induced Peripheral Neuropathy","enrollment":48},{"nctId":"NCT05950399","phase":"NA","title":"Stress Echocardiography to Identify Chemotherapy Induced Cardiotoxicity in Cancer Patients With Heart Failure Risk","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2015-06-29","conditions":"Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm","enrollment":52},{"nctId":"NCT01686334","phase":"PHASE2","title":"Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zwi Berneman","startDate":"2012-10","conditions":"Acute Myeloid Leukemia","enrollment":130},{"nctId":"NCT06266832","phase":"PHASE2","title":"The Efficacy and Safety of Short-course Radiation Combined With Adebrelimab and CAPEOX Neo-adjuvant Therapy for Organ-retention in Patients With MSS/pMMR Ultra Low Rectal Adenocarcinoma","status":"RECRUITING","sponsor":"Sir Run Run Shaw Hospital","startDate":"2024-01-01","conditions":"Rectal Adenocarcinoma","enrollment":30},{"nctId":"NCT06252584","phase":"PHASE1","title":"Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia Patients","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Tuebingen","startDate":"2024-05-02","conditions":"Acute Myeloid Leukemia, Adult","enrollment":20},{"nctId":"NCT05704855","phase":"NA","title":"A Combined Exercise Training Program for Women Living With Breast Cancer","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2023-02-01","conditions":"Breast Cancer","enrollment":21},{"nctId":"NCT05218876","phase":"NA","title":"Effects of Moderate and High-intensity Exercise During Chemotherapy on Muscle Cells in Women With Breast Cancer","status":"COMPLETED","sponsor":"Norwegian School of Sport Sciences","startDate":"2016-12-08","conditions":"Breast Cancer Female","enrollment":80},{"nctId":"NCT04754672","phase":"NA","title":"Aerobic Fitness or Muscle Mass Training to Improve Colorectal Cancer Outcome","status":"RECRUITING","sponsor":"Radboud University Medical Center","startDate":"2021-03-02","conditions":"Colorectal Cancer, Chemotherapeutic Toxicity, Survivorship","enrollment":228},{"nctId":"NCT06048146","phase":"NA","title":"A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis","status":"ENROLLING_BY_INVITATION","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2022-10-01","conditions":"Lymph Node Metastasis, Cancer of Rectum and Anus, Oxaliplatin","enrollment":180},{"nctId":"NCT04920344","phase":"PHASE2","title":"Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy","status":"UNKNOWN","sponsor":"Rutgers, The State University of New Jersey","startDate":"2021-07-19","conditions":"Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":15},{"nctId":"NCT06099951","phase":"PHASE2","title":"Total Neoadjuvant Treatment for pMMR Locally Advanced Low Rectal Cancer: Anti-PD-1 Antibody With FOLFOXIRI and Preoperative Radiation Therapy","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-11-01","conditions":"Colorectal Cancer","enrollment":53},{"nctId":"NCT06058312","phase":"NA","title":"Individual Food Preferences for the Mediterranean Diet in Cancer Patients","status":"UNKNOWN","sponsor":"Centre Antoine Lacassagne","startDate":"2023-09-04","conditions":"Neoplasms","enrollment":442},{"nctId":"NCT06043999","phase":"NA","title":"Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2023-09-01","conditions":"Chemotherapy Effect, Rectal Cancer","enrollment":392},{"nctId":"NCT01367301","phase":"NA","title":"Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer","status":"TERMINATED","sponsor":"Albert Einstein College of Medicine","startDate":"2011-07-08","conditions":"Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma","enrollment":14},{"nctId":"NCT03598218","phase":"NA","title":"Hypofractionated Versus Conventionally Fractionated Radiotherapy for Initial Distant Metastases Nasopharyngeal Carcinoma","status":"COMPLETED","sponsor":"Wei Jiang","startDate":"2018-07-13","conditions":"Nasopharyngeal Carcinoma","enrollment":30},{"nctId":"NCT02134782","phase":"NA","title":"Yoga Fatigue Study","status":"TERMINATED","sponsor":"The Hospital for Sick Children","startDate":"2014-10-02","conditions":"Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia in Relapse, Burkitt's Lymphoma Stage III","enrollment":125},{"nctId":"NCT02665065","phase":"PHASE3","title":"Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actinium Pharmaceuticals","startDate":"2016-06","conditions":"Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute","enrollment":153},{"nctId":"NCT01084083","phase":"PHASE2","title":"Induction Chemotherapy Followed By Cetuximab and Radiation in HPV-Associated Resectable Stage III/IV Oropharynx Cancer","status":"COMPLETED","sponsor":"Eastern Cooperative Oncology Group","startDate":"2010-08-11","conditions":"Head and Neck Cancer, Precancerous Condition","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Low-intensity chemotherapy regimen","genericName":"Low-intensity chemotherapy regimen","companyName":"Amgen","companyId":"amgen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Low-intensity chemotherapy regimens use reduced doses of cytotoxic agents to kill rapidly dividing cancer cells while minimizing toxicity in vulnerable patient populations. Used for Hematologic malignancies in elderly or frail patients, Acute myeloid leukemia (AML) in patients ineligible for intensive chemotherapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}